How Evaluate Supports Your Success
Accessing the breadth and depth of quality, validated data you need can be a real challenge. The different data sets required are hard to source, standardise, aggregate and correlate. And even if you can manage all that in-house, you will always benefit from an independent perspective that eliminates unconscious bias and can be used for triangulation to de-risk asset valuation and portfolio optimisation decisions. Use consensus forecasting to identify market potential, opportunities and risks to help you understand what the market is saying about competitors and product portfolios, and to validate the assumptions that inform investment decisions. Evaluate Pharma enables you to:
1
De-risk decision making
Access consensus forecasts for almost 6,000 drugs, enhanced by the most comprehensive coverage of drug sales at an indication level with coverage of 5,000 drugs at a worldwide level and 2,500 drugs at a US-specific level.
2
Analyse historical data
Understand drug progression and identify trends with 1.5m+ consensus forecasts of 10,000 products dating back to 2003.
3
Refine forecasting models
Identify outliers, and potential under- or over-forecasting for an indication over time.
4
Track deals and patents
Monitor deals by company, product, therapy area, and more. Access historical deal data, venture financing and IPO information, key patent expiration dates and sales at risk globally.
5
Monitor market trends
View a daily and weekly round-up of the stock price winners and losers, and the news impacting share prices and valuations.
6
Track product developments
Get insight into future critical events related to a product’s life cycle, and development and regulatory timelines.
